CCPG1

Across TCGA pan-cancer cohorts, CCPG1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of CCPG1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CCPG1 RNA is repressed in tumor relative to normal tissue. In most cancer types CCPG1 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LUSC, KICH, and THCA are the cancer types where CCPG1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCPG1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	III,IV	−1.665	<.001	8	view →
KICH	All	All	−0.627	<.001	5	view →
THCA	Male	III,IV	−0.574	.001	5	view →
CHOL	All	II,III,IV	+1.130	.010	4	view →
COAD	Female	All	−0.795	<.001	4	view →
BLCA	Male	All	−0.618	.012	3	view →
READ	Female	All	−0.962	<.001	2	view →
UCEC	All	All	−0.737	<.001	2	view →
LIHC	Female	All	+0.291	.020	2	view →
PRAD	All	All	+0.236	.013	2	view →
BRCA	All	All	−0.139	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

CCPG1–LUSC

Open the LUSC breakdown →